Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Variant O89 O-Antigen of E. coli Is Associated With Group 1 Capsule Loci and Multidrug Resistance.

Harris S, Piotrowska MJ, Goldstone RJ, Qi R, Foster G, Dobrindt U, Madec JY, Valat C, Rao FV, Smith DGE.

Front Microbiol. 2018 Aug 31;9:2026. doi: 10.3389/fmicb.2018.02026. eCollection 2018.

2.

Lipid remodeling and an altered membrane-associated proteome may drive the differential effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion.

Jeromson S, Mackenzie I, Doherty MK, Whitfield PD, Bell G, Dick J, Shaw A, Rao FV, Ashcroft SP, Philp A, Galloway SDR, Gallagher I, Hamilton DL.

Am J Physiol Endocrinol Metab. 2018 Jun 1;314(6):E605-E619. doi: 10.1152/ajpendo.00438.2015. Epub 2017 Jun 27.

PMID:
28655718
3.

Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.

Rao FV, Schüttelkopf AW, Dorfmueller HC, Ferenbach AT, Navratilova I, van Aalten DM.

Open Biol. 2013 Oct 2;3(10):130021. doi: 10.1098/rsob.130021.

4.

BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm.

Hobley L, Ostrowski A, Rao FV, Bromley KM, Porter M, Prescott AR, MacPhee CE, van Aalten DM, Stanley-Wall NR.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13600-5. doi: 10.1073/pnas.1306390110. Epub 2013 Jul 31. Erratum in: Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5371-5.

5.

Structure-based mutagenic analysis of mechanism and substrate specificity in mammalian glycosyltransferases: porcine ST3Gal-I.

Rakic B, Rao FV, Freimann K, Wakarchuk W, Strynadka NC, Withers SG.

Glycobiology. 2013 May;23(5):536-45. doi: 10.1093/glycob/cwt001. Epub 2013 Jan 8.

PMID:
23300007
6.

Structural and biochemical characterization of a trapped coenzyme A adduct of Caenorhabditis elegans glucosamine-6-phosphate N-acetyltransferase 1.

Dorfmueller HC, Fang W, Rao FV, Blair DE, Attrill H, van Aalten DM.

Acta Crystallogr D Biol Crystallogr. 2012 Aug;68(Pt 8):1019-29. doi: 10.1107/S0907444912019592. Epub 2012 Jul 17.

7.

Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases.

Schüttelkopf AW, Andersen OA, Rao FV, Allwood M, Rush CL, Eggleston IM, van Aalten DM.

ACS Med Chem Lett. 2011 Mar 23;2(6):428-32. doi: 10.1021/ml200008b. eCollection 2011 Jun 9.

8.

Structural insight into mammalian sialyltransferases.

Rao FV, Rich JR, Rakić B, Buddai S, Schwartz MF, Johnson K, Bowe C, Wakarchuk WW, Defrees S, Withers SG, Strynadka NC.

Nat Struct Mol Biol. 2009 Nov;16(11):1186-8. doi: 10.1038/nsmb.1685. Epub 2009 Oct 11.

PMID:
19820709
9.

Screening-based discovery and structural dissection of a novel family 18 chitinase inhibitor.

Schüttelkopf AW, Andersen OA, Rao FV, Allwood M, Lloyd C, Eggleston IM, van Aalten DM.

J Biol Chem. 2006 Sep 15;281(37):27278-85. Epub 2006 Jul 14.

10.

Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.

Rao FV, Dorfmueller HC, Villa F, Allwood M, Eggleston IM, van Aalten DM.

EMBO J. 2006 Apr 5;25(7):1569-78. Epub 2006 Mar 16.

11.

Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes.

Rao FV, Andersen OA, Vora KA, Demartino JA, van Aalten DM.

Chem Biol. 2005 Sep;12(9):973-80.

12.

Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases.

Rao FV, Houston DR, Boot RG, Aerts JM, Hodkinson M, Adams DJ, Shiomi K, Omura S, van Aalten DM.

Chem Biol. 2005 Jan;12(1):65-76.

13.

Structure of the D142N mutant of the family 18 chitinase ChiB from Serratia marcescens and its complex with allosamidin.

Vaaje-Kolstad G, Houston DR, Rao FV, Peter MG, Synstad B, van Aalten DM, Eijsink VG.

Biochim Biophys Acta. 2004 Jan 14;1696(1):103-11.

PMID:
14726210
14.

Crystal structures of allosamidin derivatives in complex with human macrophage chitinase.

Rao FV, Houston DR, Boot RG, Aerts JM, Sakuda S, van Aalten DM.

J Biol Chem. 2003 May 30;278(22):20110-6. Epub 2003 Mar 14.

Supplemental Content

Support Center